Predicted protein targets (top 1)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TSHR | P16473 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL15894731 | 0.98 | — | — | |
| SCHEMBL13324456 | 0.88 | TSHR (0.39) | TSHR | |
| SCHEMBL17148452 | 0.86 | — | — | |
| SCHEMBL11920355 | 0.84 | TSHR (0.35) | TSHR | |
| SCHEMBL12429987 | 0.82 | THRB (0.35) | TSHR | |
| SCHEMBL16921181 | 0.81 | TSHR (0.33) | TSHR | |
| SCHEMBL16804279 | 0.81 | TSHR (0.36) | TSHR | |
| SCHEMBL17449528 | 0.81 | THRB (0.43) | TSHR | |
| SCHEMBL21905023 | 0.79 | TSHR (0.42) | TSHR | |
| SCHEMBL21907146 | 0.79 | TSHR (0.32) | TSHR |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20180044448-A1 | ADDITION-FRAGMENTATION OLIGOMERS | 3M INNOVATIVE PROPERTIES COMPANY | 2018-02-15 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20180044448-A1 | ADDITION-FRAGMENTATION OLIGOMERS | ECPAS, ITGA8, NBAS | TSHR 4794/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.